George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
There's nothing left for me to take out.
I've said it before, I have no confidence in Gooding's leadership after he deserted us but I do believe in NXP002. My only hope is that someone will jump in and take it from them before it gets sold off to some minnow as part of deal that offers nothing of value to NFX shareholders.
I can see why you're hopeful, Drago:
"Major licensee technical objections regarding viability of NXP002 as an inhaled therapy are now addressed..."
What a thing to be able to boast. They should be shouting from the rooftops. Absolutely no reason for them to not make solid progress in those talks now! Is there?
That 'declaration' was made back in December. How much more convincing does this 'major licensee' need?
Dunno. Very opportune for that big seller though, wasn't it?
I always thought issuing warrants increased the number of shares in circulation. Doesn't seem to have happened in this case though (if it was indeed anything to do with warrants)
Fair enough, so you attended this presentation and heard Gooding deliver it?
I just hadn't heard about it and wondered why it was not open to everyone? It sounds like he was delivering some pretty relevant information there. As you quoted:
"Major licensee technical objections regarding viability of NXP002 as an inhaled therapy are now addressed..." that's quite a thing. Who is the major licensee?
Exactly when in December did this take place, if you don't mind spoonfeeding me just a little more?
If the US, Japan & EU are 'in the bag' then presumably, from a patent viewpoint, there is nothing to hold a partner back now?
You said they have all the data they need, just beefing it up.
So, no excuses now!
No TR1's then. Is it now safe to assume our invisible 'institutional investor' has managed to exercise and dumped everything in one transaction, so they don't have to?
I sometimes wonder if this market is regulated at all.
It makes me somewhat nervous when 30 odd million shares suddenly get dumped (especially after an unexplained rise in price). I know some are speculating that this is the 35m warrants being forward sold but it's also a very close volume to the total amount held by certain key people associated with this company.
If it is warrant related then how much grace do they normally get before they have to exercise them after selling and an RNS being released?
Not sure what that means "forward selling the warrants"?
Are you saying that the unknown "institutional investor" has suddenly acquired 35m new shares and has immediately dumped 18m of them?
Shouldn't we see an RNS saying that the warrants have been taken if that is the case?
I respect your view Jiving even though I don't necessarily agree with all of it.
I have no gripe with Julian or Maddy. They have stayed the course when all others faltered, even taking a cut in remuneration (which I hope they will be rewarded for at some point)
However, for me the critical event was Gooding resigning in 2020. I lost faith after that. That was catalyst for the downward spiral in my opinion and even though he's now back, we are still at rock bottom with only a recent increase of a fraction of a penny to give us hope the wind might be about to change. Nothing solid to back it up at all yet. No news on trial progress. Just whispers of talks (no different to the murmurs in the Allenby excerpt)
To say we are in an infinitely better place is not something I can agree with at all.
" NFX anticipates that this milestone could be achieved within the next 18 months, but with multiple opportunities for licensing NXP002 prior to this. Prospects for an early-stage deal are good judging by precedent in the IPF space."
The key is in what you said yourself Jiving. That was 3 years ago! No mention of phase readiness deadlines these days. Last I heard they were looking to acquire samples for these essential trials. When was the last time Gooding mentioned how that was going.
All we've had is absolute guff.